SANOFI-AVENTIS (EPA:SAN)

PRESS RELEASE

published on 12/24/2025 at 07:15, 2 months 29 days ago

Communiqué de presse : Sanofi va acquérir Dynavax et ajouter un vaccin commercialisé contre l’hépatite B pour adultes et un candidat vaccin de phase 1/2 contre le zona au pipeline
Sanofi acquiert Dynavax pour renforcer sa présence dans la vaccination des adultes avec un vaccin contre l'hépatite B et un candidat vaccin contre le zona. La transaction est estimée à environ 2,2 milliards de dollars. Accord approuvé par le Conseil d'administration de Dynavax

Acquisition Sanofi Vaccin Hépatite B Zona
PRESS RELEASE

published on 12/24/2025 at 07:15, 2 months 29 days ago

Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
Sanofi announces acquisition of Dynavax Technologies Corporation, expanding adult vaccine portfolio with hepatitis B and shingles candidates. Merger valued at $2.2 billion

Acquisition Sanofi Vaccines Dynavax Hepatitis B
BRIEF

published on 12/24/2025 at 07:05, 2 months 29 days ago

Sanofi Faces Delay in FDA Approval for Tolebrutinib in MS Treatment

FDA Sanofi Tolebrutinib MS Treatment Regulatory Delay
BRIEF

published on 12/24/2025 at 07:05, 2 months 29 days ago

Sanofi fait face à un retard dans l'approbation par la FDA du tolebrutinib pour le traitement de la SEP.

FDA Sanofi Tolebrutinib Retard Réglementaire Traitement De La SEP
PRESS RELEASE

published on 12/24/2025 at 07:00, 2 months 29 days ago

Communiqué de presse : Sanofi fait le point sur la soumission réglementaire du tolebrutinib dans la sclérose en plaques secondaire progressive non-récurrente
Sanofi fait le point sur la soumission réglementaire du tolebrutinib dans la sclérose en plaques secondaire progressive non-récurrente. La FDA émet une lettre de réponse complète pour le tolebrutinib contre la SEPSPnr

FDA Sclérose En Plaques Sanofi Tolebrutinib SEPSPnr
PRESS RELEASE

published on 12/24/2025 at 07:00, 2 months 29 days ago

Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Sanofi provides update on tolebrutinib regulatory submission for non-relapsing secondary progressive multiple sclerosis, with FDA issuing a complete response letter and further guidance expected in Q1 2026

FDA Multiple Sclerosis Sanofi Tolebrutinib Regulatory Submission
BRIEF

published on 12/23/2025 at 15:11, 2 months 30 days ago

Sanofi's Wayrilz receives EU approval for the treatment of IPT

EU Sanofi TPI Wayrilz BTK
BRIEF

published on 12/23/2025 at 15:11, 2 months 30 days ago

Wayrilz de Sanofi reçoit l'approbation de l'UE pour le traitement de la TPI

EU Sanofi TPI Wayrilz BTK
BRIEF

published on 12/23/2025 at 15:11, 2 months 30 days ago

Sanofi's Wayrilz Gets EU Approval for Treating Immune Thrombocytopenia

Sanofi EU Approval BTK Inhibitor Wayrilz Immune Thrombocytopenia
BRIEF

published on 12/23/2025 at 15:11, 2 months 30 days ago

Le Wayrilz de Sanofi obtient l'approbation de l'UE pour le traitement de la thrombocytopénie immunitaire

Sanofi Wayrilz Inhibiteur De BTK Thrombocytopénie Immunitaire Approbation De L'UE

Published on 03/23/2026 at 02:00, 1 hour 5 minutes ago

FutureGen Industries Announces Open Market Investments
Published on 03/20/2026 at 23:00, 2 days 4 hours ago

Cypher Announces Private Placement
Published on 03/20/2026 at 21:30, 2 days 5 hours ago

Sky Gold Sets Options
Published on 03/20/2026 at 21:15, 2 days 5 hours ago

Earthwise Minerals Announces Private Placement
Published on 03/20/2026 at 13:30, 2 days 13 hours ago

Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock

View all ACCESSWIRE

Published on 03/22/2026 at 18:22, 8 hours 43 minutes ago

Test news - please ignore EN
Published on 03/22/2026 at 12:23, 14 hours 42 minutes ago

Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 2 days 4 hours ago

Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 6 hours ago

Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 2 days 6 hours ago

Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion

View all EQS

Published on 03/20/2026 at 19:00, 2 days 8 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 8 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 8 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 8 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
Published on 03/20/2026 at 17:45, 2 days 9 hours ago

Cie du Bois Sauvage : Jaarverslag 2025

View all LES ECHOS COMFI WIRE

News